Managing advanced chronic kidney disease: A primary care guide

被引:13
作者
Sakhuja, Ankit [1 ]
Hyland, Jennifer [2 ]
Simon, James F. [2 ,3 ]
机构
[1] Mayo Clin, Div Nephrol & Hypertens, Rochester, MN USA
[2] Cleveland Clin, Glickman Urol & Kidney Inst, Dept Hypertens & Nephrol, Cleveland, OH 44195 USA
[3] Case Western Reserve Univ, Lerner Coll Med, Cleveland Clin, Cleveland, OH 44106 USA
关键词
RENIN-ANGIOTENSIN SYSTEM; CORONARY-HEART-DISEASE; STAGE RENAL-DISEASE; INTRAVENOUS IRON SUPPLEMENTATION; GLOMERULAR-FILTRATION-RATE; 3RD NATIONAL-HEALTH; ALL-CAUSE MORTALITY; CARDIOVASCULAR-DISEASE; BLOOD-PRESSURE; RISK-FACTOR;
D O I
10.3949/ccjm.81a.13046
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Chronic kidney disease (CKD) is a common disorder that requires close collaboration between the primary care physician and nephrologist. Most aspects of early CKD can be managed in the primary care setting with nephrology input. As the disease progresses, many aspects of care should be transitioned to the nephrologist, especially as the patient nears end-stage renal disease, when dialysis and transplantation must be addressed.
引用
收藏
页码:289 / 299
页数:11
相关论文
共 99 条
[1]   The impact of stopping inhibitors of the renin-angiotensin system in patients with advanced chronic kidney disease [J].
Ahmed, Aimun K. ;
Kamath, Neetha S. ;
El Kossi, Mohsen ;
El Nahas, A. Meguid .
NEPHROLOGY DIALYSIS TRANSPLANTATION, 2010, 25 (12) :3977-3982
[2]  
[Anonymous], FDA DRUG SAF COMM
[3]  
[Anonymous], 2000, Am J Kidney Dis, V35, pS1, DOI DOI 10.1053/AJKD.2000.V35.AAJKD03517
[4]  
Arora P, 1999, J AM SOC NEPHROL, V10, P1281
[5]   Proteinuria reduction and progression to renal failure in patients with type 2 diabetes mellitus and overt nephropathy [J].
Atkins, RC ;
Briganti, EM ;
Lewis, JB ;
Hunsicker, LG ;
Braden, G ;
de Crespigny, PJC ;
DeFerrari, G ;
Drury, P ;
Locatelli, F ;
Wiegmann, TB ;
Lewis, EJ .
AMERICAN JOURNAL OF KIDNEY DISEASES, 2005, 45 (02) :281-287
[6]   The effects of lowering LDL cholesterol with simvastatin plus ezetimibe in patients with chronic kidney disease (Study of Heart and Renal Protection): a randomised placebo-controlled trial [J].
Baigent, Colin ;
Landray, Martin J. ;
Reith, Christina ;
Emberson, Jonathan ;
Wheeler, David C. ;
Tomson, Charles ;
Wanner, Christoph ;
Krane, Vera ;
Cass, Alan ;
Craig, Jonathan ;
Neal, Bruce ;
Jiang, Lixin ;
Hooi, Lai Seong ;
Levin, Adeera ;
Agodoa, Lawrence ;
Gaziano, Mike ;
Kasiske, Bertram ;
Walker, Robert ;
Massy, Ziad A. ;
Feldt-Rasmussen, Bo ;
Krairittichai, Udom ;
Ophascharoensuk, Vuddidhej ;
Fellstrom, Bengt ;
Holdaas, Hallvard ;
Tesar, Vladimir ;
Wiecek, Andrzej ;
Grobbee, Diederick ;
de Zeeuw, Dick ;
Gronhagen-Riska, Carola ;
Dasgupta, Tanaji ;
Lewis, David ;
Herrington, William ;
Mafham, Marion ;
Majoni, William ;
Wallendszus, Karl ;
Grimm, Richard ;
Pedersen, Terje ;
Tobert, Jonathan ;
Armitage, Jane ;
Baxter, Alex ;
Bray, Christopher ;
Chen, Yiping ;
Chen, Zhengming ;
Hill, Michael ;
Knott, Carol ;
Parish, Sarah ;
Simpson, David ;
Sleight, Peter ;
Young, Alan ;
Collins, Rory .
LANCET, 2011, 377 (9784) :2181-2192
[7]   Differential effects of calcium antagonist subclasses on markers of nephropathy progression [J].
Bakris, GL ;
Weir, MR ;
Secic, M ;
Campbell, B ;
Weis-McNulty, A .
KIDNEY INTERNATIONAL, 2004, 65 (06) :1991-2002
[8]   Timing of first cannulation of arteriovenous fistula: time matters, but there is also something else [J].
Basile, C ;
Casucci, F ;
Lomonte, C .
NEPHROLOGY DIALYSIS TRANSPLANTATION, 2005, 20 (07) :1519-1520
[9]   The natural history of autologous fistulas as first-time dialysis access in the KDOQI era - Discussion [J].
Sykes, Mellick T. ;
Biuckians, Andre .
JOURNAL OF VASCULAR SURGERY, 2008, 47 (02) :420-421
[10]   Prevalence of hypertension in 1,795 subjects with chronic renal disease: The modification of diet in renal disease study baseline cohort [J].
Buckalew, VM ;
Berg, RL ;
Wang, SR ;
Porush, JG ;
Rauch, S ;
Schulman, G .
AMERICAN JOURNAL OF KIDNEY DISEASES, 1996, 28 (06) :811-821